Avantor® Participates in BioProcess International 2024 Conference Scientific Program and Exhibition

Rhea-AI Summary

Avantor, Inc. (NYSE: AVTR) announced its participation in the BioProcess International 2024 conference, scheduled for September 23-26 in Boston. The company will deliver multiple scientific presentations and exhibit at the event, which is expected to attract over 3,200 biopharmaceutical professionals from 40+ countries.

Key presentations include:

• A novel approach to AAV harvest and purification process optimization
• Keynote address on adapting to changing molecules and regulatory expectations
• Viral gene therapy manufacturing at scale

Avantor will also showcase its Magnetic Mixing Systems portfolio on the exhibit floor, focusing on solutions for production scale-up and downstream process optimization. The company's presence at the conference underscores its commitment to delivering innovative solutions for biopharmaceutical development and production challenges.

Positive

• Avantor is presenting multiple scientific sessions at a major industry conference, demonstrating thought leadership
• The company is showcasing its Magnetic Mixing Systems portfolio, highlighting product innovation
• Participation in the conference provides networking opportunities with potential customers

Negative

• None.

News Market Reaction

-1.52%

1 alert

-1.52% News Effect

On the day this news was published, AVTR declined 1.52%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

RADNOR, Pa., Sept. 23, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced the Company will deliver multiple scientific presentations and exhibit at BioProcess International 2024, scheduled for September 23-26 in Boston. Over 3,200 biopharmaceutical development and production professionals representing 40-plus countries are expected to attend.

Avantor's scientific presentations at BioProcess International 2024 include:

Presenter - Jungmin Oh, Ph.D., Senior Manager, New Product Development
Session Title - A novel approach to optimization of AAV harvest and purification process
Date and Time - September 25, 12:30 pm

Presenter - Nandu Deorkar, Ph.D., Senior Vice President, Biopharma Production Research & Development
Session Title - Keynote Address: Adapting to Changing Molecules and Regulatory Expectations
Date and Time – September 26, 10:00 am

Presenter - Jerry Keybl, Ph.D., Senior Vice President, Biopharma Products & Strategy
Session Title - Viral Gene Therapy Manufacturing at Scale – Assembling Solutions to Drive Industrialization
Date and Time - September 26, 12:15 pm

"Avantor's significant presence at BioProcess International 2024 is a testament to our reputation for delivering leading solutions across the spectrum of biopharmaceutical development and production," said Benoit Gourdier, Executive Vice President and Head of Avantor's Bioscience Production Segment. "We look forward to engaging with customers and attendees in Boston and showcasing how our innovative solutions can help solve their most demanding production challenges."

In addition to its multiple scientific presentations, Avantor will also have a strong presence on the exhibit floor, focusing on its industry leading solutions for production scale up and downstream process optimization. Avantor will present its Magnetic Mixing Systems portfolio, which ranges from 50 to 1500 liters, and now includes a newly launched tabletop mixer for single-use mixing needs. These scalable Magnetic Mixing Systems are designed to maximize mixing efficiency with low shear rates, ensuring consistent homogeneity and minimizing risk to product quality. Avantor's experienced team of engineers can also help design specialized solutions tailored to customers unique bioprocessing mixing needs.

About Avantor
Avantor^® is a leading life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. We work side-by-side with customers at every step of the scientific journey to enable breakthroughs in medicine, healthcare, and technology. Our portfolio is used in virtually every stage of the most important research, development and production activities at more than 300,000 customer locations in 180 countries. For more information, visit avantorsciences.com and find us on LinkedIn, X (Twitter) and Facebook.

Global Media Contact
Eric Van Zanten
Head of External Communications
Avantor
610-529-6219
Eric.VanZanten@avantorsciences.com

Investor Relations Contact
Christina Jones
Vice President, Investor Relations
Avantor
805-617-5297
Christina.Jones@avantorsciences.com

View original content:https://www.prnewswire.com/news-releases/avantor-participates-in-bioprocess-international-2024-conference-scientific-program-and-exhibition-302254597.html

SOURCE Avantor and Financial News

FAQ

What is Avantor's (AVTR) role in BioProcess International 2024?

Avantor (AVTR) is delivering multiple scientific presentations and exhibiting at BioProcess International 2024, showcasing their solutions for biopharmaceutical development and production.

When and where is BioProcess International 2024 taking place?

BioProcess International 2024 is scheduled for September 23-26 in Boston.

What products will Avantor (AVTR) be showcasing at BioProcess International 2024?

Avantor (AVTR) will be showcasing its Magnetic Mixing Systems portfolio, ranging from 50 to 1500 liters, including a newly launched tabletop mixer for single-use mixing needs.

Who are the key presenters from Avantor (AVTR) at BioProcess International 2024?

Key presenters from Avantor (AVTR) include Jungmin Oh, Ph.D., Nandu Deorkar, Ph.D., and Jerry Keybl, Ph.D., who will discuss topics such as AAV purification, regulatory expectations, and viral gene therapy manufacturing.